Strategies to Manage Antibody Drug Conjugates (ADC) - Related Toxicities in Breast Cancer : Episode 1
Opinion
Video
Overview of Current ADCs in Breast Cancer
Author(s):
Medical experts review the currently available antibody-drug conjugates for breast cancer, including Sacituzumab govitecan (Trop-2 directed ADC), Kadcyla (ado-trastuzumab emtansine, T-DM1, HER2-directed ADC), and Enhertu (fam-trastuzumab deruxtecan-nxki, T-DXd, HER2-directed ADC).
Video content above is prompted by the following:
- Can you briefly review which currently available antibody-drug conjugates we have for breast cancer?
Related Videos
Related Content
